Q3 2024 Holdings
Filed 2024-11-13 | 112 holdings | $2.0B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $51.9M | 347,921 | 2.6% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $52.1M | 3,258,677 | 2.6% |
| IGM Biosciences Inc(1K0) | COM | 449585108 | $55.1M | 3,330,422 | 2.8% |
| Lexicon Pharmaceuticals Inc(LXRX) | COM NEW | 528872302 | $61.1M | 38,918,903 | 3.1% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $62.5M | 2,167,224 | 3.1% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $66.2M | 1,440,736 | 3.3% |
| Crinetics Pharmaceuticals Inc(CRNX) | COM | 22663K107 | $66.9M | 1,309,652 | 3.3% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $77.9M | 143,647 | 3.9% |
| Bicara Therapeutics Inc(BCAX) | COM | 055477103 | $78.3M | 3,072,827 | 3.9% |
| Scholar Rock Holding Corp(SRRK) | COM | 80706P103 | $90.2M | 11,259,438 | 4.5% |
| Beigene Ltd(ONC) | SPONSORED ADR | 07725L102 | $126.5M | 563,314 | 6.3% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $140.6M | 2,969,733 | 7.0% |